EchoGo Pro vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Ultromics
VS
by Powerful Medical

AI Verdict

Both Ultromics' EchoGo Pro and Powerful Medical's PMcardio are AI-powered cardiology tools, but they focus on different diagnostic modalities. EchoGo Pro specializes in automating stress echocardiography analysis for coronary artery disease, while PMcardio interprets ECGs to detect a broader range of cardiac conditions. Therefore, the choice between them depends on whether the primary need is advanced echocardiogram analysis or rapid, comprehensive ECG interpretation.

Choose EchoGo Pro if…

Choose EchoGo Pro if your cardiology department requires an FDA-cleared, AI-powered cloud solution for automated stress echocardiography analysis, aiming to improve the diagnostic accuracy of coronary artery disease (CAD) and generate near-instant, comprehensive reports. This tool is ideal for reducing subjectivity in interpretation and integrating seamlessly with existing PACS and clinical workflows for enhanced efficiency.

View EchoGo Pro →

Choose PMcardio if…

Choose PMcardio if you need a CE-certified AI platform for rapid and accurate interpretation of ECGs, particularly in emergency medicine or primary care settings, to assess over 50 cardiac conditions at the point of care. It's well-suited for clinicians who require instant, expert-level ECG interpretations, including STEMI/OMI detection and reduced LVEF, with visual AI explainability and mobile accessibility.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EchoGo Pro PMcardio
Pricing Contact vendor for pricing Freemium
Deployment Cloud-based (SaaS) Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, allowing for immediate use by individual clinicians without IT integration. It supports any 12-lead ECG image, which can be easily scanned via a smartphone. EchoGo Pro is cloud-based and integrates with existing clinical workflows, but its deployment seems more geared towards enterprise-level integration rather than immediate individual use.

Clinical Value

PMcardio

PMcardio detects over 50 cardiac conditions from ECGs, including STEMI/OMI and reduced LVEF, and has been clinically validated in more than 25 studies. EchoGo Pro focuses on automating stress echocardiography analysis for coronary artery disease (CAD) diagnosis, with a diagnostic performance of over 90% (AUROC) in trials. While both offer significant clinical value, PMcardio's broader diagnostic scope across numerous cardiac conditions from a readily available ECG gives it an edge in versatility and immediate point-of-care impact.

Pricing & Value

PMcardio

PMcardio offers a freemium model with 5 free ECG analyses per month and a transparent Pro Plan for individuals at u20ac30/month, making it accessible for individual clinicians to try and adopt. EchoGo Pro requires contacting the vendor for pricing, which suggests a less transparent and potentially higher-cost enterprise-focused model.

Enterprise Readiness

PMcardio

Both tools demonstrate strong enterprise readiness. EchoGo Pro is a cloud-based SaaS solution with seamless integration into PACS and existing clinical workflows (DICOM, HL7). PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, with a unified cardiac AI platform that supports the full cardiac care journey and is built for regulated healthcare environments with SOC 2 Type II, ISO 27001, GDPR, and HIPAA compliance. PMcardio's comprehensive suite of offerings for organizations, including various clinical suites and a single integration model, gives it a slight advantage in addressing diverse enterprise needs.

Innovation

Tie

Both tools showcase significant innovation in their respective domains. EchoGo Pro is a world-first, FDA-cleared AI-powered solution for automated stress echocardiography analysis to diagnose CAD. PMcardio offers AI explainability with heatmaps (ECGxplainu2122) and detects over 50 cardiac conditions from ECGs, including novel STEMI and OMI detection (Queen of Heartsu2122) and reduced LVEF detection (LVsenseu2122). Both are pushing the boundaries of AI in cardiology, making it difficult to pick a definitive winner in this dimension.

Support & Docs

PMcardio

PMcardio provides a Help Center with user-friendly tutorials and manuals, as well as a dedicated section for regulatory and security documentation. While EchoGo Pro mentions customer support, specific details about the breadth and accessibility of their documentation and support resources are not as readily available in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EchoGo Pro PMcardio
Name EchoGo Pro PMcardio
Company Ultromics Powerful Medical
Description EchoGo Pro is an FDA-cleared, AI-powered cloud solution by Ultromics that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, providing near-instant, accurate reports. PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care.
Primary Function Automated stress echocardiography analysis for coronary artery disease (CAD) diagnosis. AI-powered ECG interpretation for over 50 cardiac conditions.
Regulatory Clearance FDA-cleared CE-certified (Class IIb medical device under MDR)
Key Features AI-powered automated echocardiogram analysis, Cloud-based service, Automated identification of coronary artery disease (CAD), Near-instant, comprehensive reports, Vendor-neutral system, Seamless integration with existing clinical workflows (DICOM, HL7), SaaS model requires no software installation or extensive training. Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses, Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization.
Specialties Cardiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring EchoGo Pro and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EchoGo Pro is a cloud-based service designed for seamless integration with existing clinical workflows, supporting DICOM and HL7, and is compatible with any PACS. PMcardio offers integrations with EHR/CVIS and EMS systems, and its detailed PDF reports, including patient and ECG information, can be exported and integrated into patients' electronic health records.
EchoGo Pro has demonstrated a sensitivity of 84.4% and specificity of 92.7% for identifying severe coronary artery disease, and its use has been shown to improve clinicians' sensitivity by 10%. PMcardio has shown a sensitivity of 86% and specificity of 92% for major ECG abnormalities, and 97% sensitivity and 99% specificity for atrial fibrillation. For STEMI detection, PMcardio's Queen of Hearts platform achieved 92% sensitivity and 81% specificity, outperforming standard processes.
EchoGo Pro is a SaaS model that requires no software installation or extensive training, suggesting a potentially quick time-to-value. PMcardio allows clinicians to start using its AI-powered ECG interpretation immediately by downloading the mobile or web app, with no IT integration required, indicating a rapid time-to-value.
Ultromics' EchoGo Pro has been rolled out in the NHS and assessed at Mayo Clinic, with trials conducted in the UK and US. PMcardio is trusted by over 100,000 clinicians across 150+ hospitals worldwide and has numerous clinical validation studies and case studies available, including instances where it helped reduce false positive STEMI alerts and improve diagnostic accuracy in emergency settings.
EchoGo Pro includes audit logging as a security feature. PMcardio also supports full audit trails within its enterprise-ready deployment for organizations.
EchoGo Pro is a cloud-based service, offering scalability and accessibility for potentially multi-site use. PMcardio for Organizations is purpose-built for multi-pathway, multi-site cardiac care delivery, offering enterprise-ready deployment with one integration and one security review that scales across campuses and care settings.
EchoGo Pro is specifically designed for automating stress echocardiography analysis to improve the diagnosis of coronary artery disease, making it highly beneficial in cardiology for enhanced cardiac diagnosis and reducing misdiagnosis in stress echo readings. PMcardio, with its instant AI-powered ECG interpretations for over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, is valuable across cardiology, emergency medicine, and internal medicine, particularly for rapid, expert-level interpretations at the point of care and for guiding treatment recommendations based on ESC guidelines.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.